Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas

Medicine & Life Sciences

• Hyperprolactinemia 100%
• Dopamine Agonists 89%
• Prolactin 78%
• Adenoma 74%
• Psychology 53%
• Disruptive, Impulse Control, and Conduct Disorders 37%
• Psychiatry 26%
• Prolactinoma 23%
• Depression 17%
• Psychotic Disorders 16%
• Therapeutics 12%
• Prospective Studies 11%
• Impulsive Behavior 9%
• Risk Management 9%
• Pituitary Neoplasms 9%
• Control Groups 9%
• Bipolar Disorder 8%
• Duration of Therapy 8%
• Personality 7%
• Mental Disorders 7%
• PubMed 7%
• Anxiety 6%
• Clinical Studies 6%
• Retrospective Studies 5%
• Healthy Volunteers 5%
• Cross-Sectional Studies 5%
• Quality of Life 5%
• Pathology 5%
• Physicians 5%